Yong Wei

ORCID: 0000-0002-7615-6883
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Liver Disease and Transplantation
  • Liver Disease Diagnosis and Treatment
  • Organ Transplantation Techniques and Outcomes
  • Hepatocellular Carcinoma Treatment and Prognosis
  • Colorectal Cancer Surgical Treatments
  • Colorectal and Anal Carcinomas
  • Hepatitis B Virus Studies
  • Radioactive element chemistry and processing
  • Metal complexes synthesis and properties
  • Crystallography and molecular interactions
  • X-ray Diffraction in Crystallography
  • Crystal structures of chemical compounds
  • Bladder and Urothelial Cancer Treatments
  • Cancer Research and Treatments
  • Boron Compounds in Chemistry
  • Organ Donation and Transplantation
  • Hernia repair and management
  • Molecular Sensors and Ion Detection
  • Chemical Synthesis and Characterization
  • Colorectal Cancer Screening and Detection
  • Crystallization and Solubility Studies
  • Anorectal Disease Treatments and Outcomes
  • Intestinal Malrotation and Obstruction Disorders
  • Enhanced Recovery After Surgery
  • Intestinal and Peritoneal Adhesions

Fujian Medical University
2017-2023

Union Hospital
2019-2023

First Affiliated Hospital of Fujian Medical University
2017

Sichuan University
2011-2016

West China Hospital of Sichuan University
2011-2012

Xi'an Peihua University
2001

Background/Aims The number of people undergoing living donor liver transplantation (LDLT) has increased rapidly in many transplant centres. Patients considering LDLT need to know whether is riskier than deceased (DDLT). aim this study was compare the outcomes patients versus DDLT. Methods A total 349 with benign diseases were recruited from 2005 2011 for study. performed 128 patients, and DDLT 221 patients. Pre- intra-operative variables two groups compared. Statistically analysed...

10.1371/journal.pone.0027366 article EN cc-by PLoS ONE 2011-11-07

OBJECTIVES: To identify the factors influencing blood loss and secondary transfusion to investigate outcomes of patients who underwent a massive (MBT) following living donor liver transplantation (LDLT). METHODS: Patients primary adult‐to‐adult right hepatic lobe LDLT were included in study, divided into MBT group [≥ 6 red cell (RBC) units 24 h] non‐massive (NMBT) (< RBC h). All potential risk factors, length intensive care unit (ICU) stay long‐term survival rate two groups analyzed....

10.1111/j.1751-2980.2011.00570.x article EN Journal of Digestive Diseases 2011-12-05

Although older age theoretically might be a negative risk factor for liver transplantation (LT) outcomes, alone should not exclude patient from waiting list. This study is to investigate the outcomes of elderly hepatocellular carcinoma (HCC) living donor (LDLT) recipients which meet Milan criteria. A retrospective was performed in single center. Demographic and clinical data 110 HCC LDLT January 2004 December 2012 were collected analyzed, including 31 group E (≥60 years) 79 younger Y (<60...

10.1097/md.0000000000002499 article EN cc-by-nc Medicine 2016-02-01

Background . Self-expanding metal stents (SEMS) have been increasingly used in patients with obstructive left-sided colorectal cancer (OLCC); however, stent-specific complications (e.g., perforations) might worsen the long-term survival outcome. Strict indication needed to be identified confirm benefit subgroups. This study was designed explore for emergency surgery (ES) and SEMS OLCC suggest optimal strategies individuals. Methods After propensity score matching, 36 pairs were included....

10.1155/2019/7418348 article EN cc-by Gastroenterology Research and Practice 2019-02-03
Coming Soon ...